Genotyping in Sickle Cell Disease Patients: The French Strategy

被引:21
|
作者
Floch, Aline [1 ,2 ,3 ,4 ]
Tournamille, Christophe [1 ,2 ,3 ]
Chami, Btissam [1 ]
Pirenne, France [1 ,2 ,3 ,4 ]
机构
[1] Etab Francais Sang EFS Ile de France, Creteil, France
[2] INSERM U955, Equipe Transfus & Malad Globule Rouge 2, Creteil, France
[3] Lab Excellence GR Ex, Creteil, France
[4] UPEC, Fac Med, IMRB, Creteil, France
关键词
Sickle cell disease; Transfusion medicine; Blood group genotyping; RH antigens; Partial antigens; HEMOLYTIC TRANSFUSION REACTION; ENCODES PARTIAL C; CLINICALLY RELEVANT; BLACK INDIVIDUALS; MOLECULAR-BASIS; RHD ALLELES; RHCE; ALLOIMMUNIZATION; PHENOTYPES; ANTIGEN;
D O I
10.1159/000490858
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review presents the French strategy for blood group genotyping in high-responder and newly diagnosed sickle cell disease (SCD) patients. In addition to FY, JK, and MNS genotyping, the RH blood group system is now explored in SCD patients in France. Molecular typing has been used for the deduction of partial RH2 (C) antigens since 2010, and the gradual implementation of systematic RHD and RHCE genotyping nationwide was initiated in late 2014. In our laboratory, 962 RH: 2 (C-positive) SCD patients have been tested since 2010, and 1,148 SCD patients of all RH phenotypes have been genotyped for clinically relevant alleles of RHD and RHCE since late 2014. (C) 2018 S. Karger GmbH, Freiburg
引用
收藏
页码:264 / 270
页数:7
相关论文
共 50 条
  • [1] Genotyping and the Future of Transfusion in Sickle Cell Disease
    Karafin, Matthew S.
    Howard, Jo
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 36 (06) : 1271 - 1284
  • [2] Audit of red cell genotyping in sickle cell disease patients in two London trusts
    Hui, Y. M. T.
    Gurung, K.
    Mkandawire, C.
    Kiilu, P.
    Lund, K.
    Ibidapo, M.
    Layton, D. M.
    Regan, F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 175 - 175
  • [3] The Emerging Role of RH Genotyping in Chronically Transfused Sickle Cell Disease Patients
    Fasano, Ross
    Monaco, Alessandro
    Meier, Emily Riehm
    Otridge, John
    Lee-Stroka, Hallie
    Pary, Philippe
    Klein, Harvey G.
    Marincola, Francesco M.
    Luban, Naomi L. C.
    Stroncek, David
    BLOOD, 2008, 112 (11) : 1043 - 1044
  • [4] Genotyping for DO A/DO B facilitates transfusion of sickle cell disease patients
    Castilho, L
    Rios, M
    Carvalho, MM
    Pellegrino, J
    Violati, RG
    Saad, ST
    Costa, FF
    TRANSFUSION, 2001, 41 (09) : 101S - 101S
  • [5] RBC Antigen Genotyping: A Valuable Tool for Managing Patients with Sickle Cell Disease
    Shirey, R. S.
    Roots, A. H.
    Boyd, J.
    King, K. E.
    Tobian, A.
    Ness, P. M.
    TRANSFUSION, 2010, 50 : 153A - 153A
  • [6] NEW STRATEGY FOR SICKLE CELL DISEASE
    DIGGS, LW
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 218 (11): : 1693 - &
  • [7] Sickle cell disease patients in two London trusts: Genotyping including RH variants
    Hui, Yee Man Tracy
    Gurung, Kamala
    Layton, David Mark
    Ibidapo, Mercy
    Grimsley, Shane
    Regan, Fiona
    TRANSFUSION MEDICINE, 2022, 32 (03) : 210 - 220
  • [8] Kidney Transplantation in Patients With Sickle Cell Disease: A French Multicenter Study
    Duquesne, A.
    Habibi, A.
    Audard, V.
    Dahan, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 569 - 570
  • [9] RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients
    Dezan, Marcia R.
    Ribeiro, Ingrid Helena
    Oliveira, Valeria B.
    Vieira, Juliana B.
    Gomes, Francisco C.
    Franco, Lucas A. M.
    Varuzza, Leonardo
    Ribeiro, Roberto
    Chinoca, Karen Ziza
    Levi, Jose Eduardo
    Krieger, Jose Eduardo
    Pereira, Alexandre Costa
    Gualandro, Sandra F. M.
    Rocha, Vanderson G.
    Mendrone-Junior, Alfredo
    Sabino, Ester Cerdeira
    Dinardo, Carla Luana
    BLOOD CELLS MOLECULES AND DISEASES, 2017, 65 : 8 - 15
  • [10] RHCE and Kell genotyping and alloimmunization profile in patients with sickle cell disease in the Federal District of Brazil
    Leite, Larissa Espindola
    da Silva, Fabio Goncalves
    Kashima, Simone
    Rodrigues, Evandra Strazza
    Haddad, Rodrigo
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (03) : 261 - 267